The clock regulator Bmal1 protects against muscular dystrophy

https://doi.org/10.1016/j.yexcr.2020.112348Get rights and content

Highlights

  • •

    Genetic loss of Bmal1 in mdx mice aggravated muscle damage with wasting and impaired function.

  • •

    Bmal1 deficiency in mdx mice resulted in severe muscle injury in diaphragm with defective regenerative response.

  • •

    Bmal1 is required for satellite cell proliferation and regenerative myogenesis to protect against dystrophic- injury.

Abstract

The muscle-intrinsic clock machinery is required for the maintenance of muscle growth, remodeling and function. Our previous studies demonstrated that the essential transcription activator of the molecular clock feed-back loop, Brain and Muscle Arnt-Like 1(Bmal1), plays a critical role in myogenic progenitor behavior to promote and regenerative myogenesis. Using genetic approaches targeting Bmal1 in the DMDmdx (mdx) dystrophic mouse model, here we report that the loss of Bmal1 function significantly accelerated dystrophic disease progression. In contrast to the mild dystrophic changes in mdx mice, the genetic loss-of-function of Bmal1 aggravated muscle damage in this dystrophic disease background, as indicated by persistently elevated creatine kinase levels, increased injury area and reduced muscle grip strength. Mechanistic studies revealed that markedly impaired myogenic progenitor proliferation and myogenic response underlie the defective new myofiber formation in the chronic dystrophic milieu. Taken together, our study identified the function of pro-myogenic clock gene Bmal1 in protecting against dystrophic damage, suggesting the potential for augmenting Bmal1 function to ameliorate dystrophic or degenerative muscle diseases.

Introduction

Repeated contraction-induced degeneration-regeneration cycles, a hallmark of dystrophic diseases such as Duchene muscular dystrophy (DMD), lead to progressive loss of muscle mass and function [1,2]. Effective means to augment regenerative repair to promote muscle growth and improve muscle mass could ameliorate dystrophic pathophysiology and potentially benefit patients with DMD [[3], [4], [5]]. Therefore, better understanding of molecular events that promote regenerative capacity could offer novel options to preserves functional muscle mass and ameliorate muscular dystrophy.

The circadian clock that drives 24-h rhythms in physiology comprise of a transcriptional-translational feedback loop that ultimately coordinates physiological processes with external timing cues [6]. In addition to the central clock residing in the suprachiasmatic nuclei entrained directly to light input, nearly all tissue and cell types in our body possess cell-autonomous clock rhythms that are normally driven by central clock. Skeletal muscle possesses intrinsic clock activity, which can be shifted by timing of exercise besides being driven by the central clock output. The clock transcription negative feedback loop underlies the ~24 h rhythms in behavior and physiology. Brain and Muscle Arnt-Like 1 (Bmal1), a muscle-enriched clock transcription activator, is essential for driving molecular clock transcription together with its heterodimer partner, Circadian Locomotor Output Cycles Kaput (CLOCK). Transcription activation of the repressors of the clock loop, including Periods (Per) and Cryptochromes (Cry), leads to subsequent inhibition of transcription to form the feedback loop. Various posttranscriptional and posttranslational mechanisms further contribute to establish the circadian oscillation cycles.

Skeletal muscle possesses cell-autonomous molecular clocks that are critical for temporal control of muscle function by entraining locomotor activity [[7], [8], [9]]. Recent studies indicated that the muscle-intrinsic clock is required for maintenance of muscle mass, growth and metabolic regulation [10,11]. This temporal element is involved in muscle mass regulation through sarcomeric structural organization and myogenic progenitor behaviors [[12], [13], [14], [15]]. We demonstrated previously that the essential clock activator Bmal1 promotes regenerative myogenesis and prevents sarcopenia [14,[16], [17], [18]]. More recently, our study revealed that Rev-erbα, a ligand-dependent nuclear receptor and transcriptional repressor of Bmal1 in the core clock loop [19,20], suppresses myogenic progenitor proliferation and differentiation [21]. In addition, Cry2 was found to be critical for circadian regulation of myogenic differentiation [22]. The circadian clock circuit may exert temporal control of myogenic progression, and thus represent a potential novel pathway for muscle-wasting disease intervention.

Utilizing the mdx mice as a DMD disease model, we generated double-null mutant of Bmal1 with the DMD disease background to directly test whether Bmal1 protects against dystrophic muscle injury. Our study revealed that the loss of Bmal1 significantly exacerbates dystrophic pathology in the mdx mice, demonstrating that Bmal1 maintains muscle regenerative capacity in muscular dystrophy.

Section snippets

Materials and methods

Animals Animals were maintained in the Beckman Research Institute of City of Hope vivarium under a constant 12:12 light dark cycle, with lights on at 7:00 a.m. (ZT0). All experiments were approved by the IACUC committee of the Beckman Research Institute of City of Hope. Bmal1-null (Arntltm1Bra, Stock No: 009100) and mdx mutant mice (Dmdmdx, Stock No: 001801) were originally purchased from the Jackson Laboratory. Mice were crossed for three generations to obtain double homozygote mutants.

RNA

Dynamic regulation of Bmal1 during mdx disease progression and loss of clock regulation in Bmal1/Dmd mutants

Dystrophic disease pathology in mdx mice displays a progressive phenotype with a severe degenerative phase starting at 7–8 weeks of age, followed by regenerative repair and a repetitive injury-induced chronic fibrotic response in older animals [2,24]. We first examined the regulation of the Bmal1 in mdx mice at 8, 20 and over 26 weeks of age. Bmal1 protein was persistently induced in mdx mice as compared to normal wild-type controls (WT) at the same age. This Bmal1 induction could be due to the

Discussion

The current mainstay of dystrophic disease treatment strategies still relies on anti-inflammatory therapy to preserve muscle function despite the underlying cause of repetitive muscle damage and resultant loss of muscle regenerative capacity [25]. Better understanding of molecular pathways contributing to dystrophic disease development is imperative for uncovering novel targets for interventions. Through genetic ablation of Bmal1 in mdx dystrophic disease model, our current study revealed an

Credit authorship statement

HG: data curation and investigation, formal analysis, manuscript writing and editing; XX, YL and SC: data curation and investigation; KM: formal analysis, project administration, manuscript writing and editing, and funding acquisition.

Declaration of competing interest

None.

Acknowledgement

We thank the Shared Resources Core Facility of City of Hope for their expert technical assistance in histology. This project was supported by grant from Muscular Dystrophy Association 381294 to KM.

References (36)

  • G. Wolff et al.

    Scheduled exercise phase shifts the circadian clock in skeletal muscle

    Med. Sci. Sports Exerc.

    (2012)
  • S. Chatterjee et al.

    Circadian clock regulation of skeletal muscle growth and repair

    (2016)
  • B.D. Harfmann et al.

    Circadian rhythms, the molecular clock, and skeletal muscle

    J. Biol. Rhythm.

    (2015)
  • J.L. Andrews et al.

    CLOCK and BMAL1 regulate MyoD and are necessary for maintenance of skeletal muscle phenotype and function

    Proc. Natl. Acad. Sci. U. S. A.

    (2010)
  • B. Guo et al.

    The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway

    Faseb. J.

    (2012)
  • S. Chatterjee et al.

    Brain and muscle Arnt-like 1 is a key regulator of myogenesis

    J. Cell Sci.

    (2013)
  • D. Nam et al.

    Novel function of rev-erbalpha in promoting Brown adipogenesis

    Sci. Rep.

    (2015)
  • R.V. Kondratov et al.

    Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock

    Genes Dev.

    (2006)
  • Cited by (13)

    • Satellite cell-specific deletion of Cipc alleviates myopathy in mdx mice

      2022, Cell Reports
      Citation Excerpt :

      Bmal1−/− mice display reduced muscle mass and body weight, which is rescued by muscle-specific expression of Bmal1 (Kondratov et al., 2006; McDearmon et al., 2006). Genetic loss of function of Bmal1 aggravated muscle damage in the dystrophic mouse model (mdx) (Gao et al., 2020). CLOCK mutant mice display a 1.8-fold reduction in mean daily locomotor activity relative to the wild-type mice (Pastore and Hood, 2013).

    • Running skeletal muscle clocks on time— the determining factors

      2022, Experimental Cell Research
      Citation Excerpt :

      As an underlying mechanism, the absence of Bmal1 was shown to cause alteration of the WNT-βcatenin signaling pathway, essential for muscle development. Notably, in the context of Duchenne muscular dystrophy, the lack of BMAL1 contributes to a more severe phenotype characterized by a further defect in the regenerative response, demonstrating that BMAL1 protects against dystrophic muscle injury [48]. It is tempting to speculate that, given the circadian regulation of many genes involved in regeneration, the time of injury could also play a role in this process.

    • Inhibition of Rev-erbα ameliorates muscular dystrophy

      2021, Experimental Cell Research
      Citation Excerpt :

      These findings indicate the direct regulatory role of Rev-erbα in myogenic progenitors (MPC) function rather than a consequence of muscle damage-induced satellite cell response. Various components of the clock circuit are known to orchestrate myogenesis, including Bmal1 and Cry2 [16,40,47]. As a direct Rev-erbα transcription target, Bmal1 was markedly induced in Rev-erbα/mdx-double null muscle as compared to mdx controls.

    View all citing articles on Scopus
    View full text